title: Complications of treatment of small cell carcinoma of the lung. Experience from a recent Canadian trial.
authors.affiliation: Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Canada.
authors.forename: R
authors.initials: R
authors.lastname: Feld
authors.forename: D
authors.initials: D
authors.lastname: Payne
authors.forename: I
authors.initials: I
authors.lastname: Hodson
authors.forename: P
authors.initials: P
authors.lastname: Coy
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide